Literature DB >> 21301481

Understanding human T-cell-mediated immunoregulation through herpesviruses.

Scott R Burrows1, Denis J Moss, Rajiv Khanna.   

Abstract

Human herpesviruses have coevolved with humans over millions of years, and adaptation of latent infection within the cells of the immune system is a unique characteristic of many of these viruses. Following primary infection, these herpesviruses establish an asymptomatic-persistent infection in healthy individuals that is strictly controlled by virus-specific CD8(+) and CD4(+) T cells. Here, we provide a brief overview of how the human immune system interacts with these latent viruses and regulates the lifelong host-virus relationship in healthy virus carriers. Extensive studies on T-cell-mediated immune regulation over the last decade has allowed researchers to successfully translate these findings into the clinical setting to treat various herpesvirus-associated diseases in transplant patients and individuals with virus-associated malignancies. It is highly likely that these newly emerging T-cell-based therapeutic and diagnostic technologies will revolutionize the clinical management of patients with herpesvirus-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301481     DOI: 10.1038/icb.2010.136

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  6 in total

Review 1.  The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Authors:  Ann M Moormann; Cynthia J Snider; Kiprotich Chelimo
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

Review 2.  Effects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex-I mediated antigen presentation.

Authors:  Pierre Murat; Judy Tellam
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-09-26       Impact factor: 9.957

3.  mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.

Authors:  Judy T Tellam; Jie Zhong; Lea Lekieffre; Purnima Bhat; Michelle Martinez; Nathan P Croft; Warren Kaplan; Ross L Tellam; Rajiv Khanna
Journal:  PLoS Pathog       Date:  2014-10-09       Impact factor: 6.823

Review 4.  T cell memory in the context of persistent herpes viral infections.

Authors:  Nicole Torti; Annette Oxenius
Journal:  Viruses       Date:  2012-07-20       Impact factor: 5.048

Review 5.  Cellular immune therapy for viral infections in transplant patients.

Authors:  Rajiv Khanna; Corey Smith
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

6.  Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity.

Authors:  Vijayendra Dasari; Corey Smith; Andrea Schuessler; Jie Zhong; Rajiv Khanna
Journal:  Hum Vaccin Immunother       Date:  2014-01-24       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.